Rapid RV/LV vs uOmnispace.MR

Similar category, different focus. These tools serve overlapping but distinct needs. Comparability 60/100 Comparability is an AI-graded 0–100 score of how directly these two tools compete — higher means a more apples-to-apples comparison.
by RapidAI
VS
by United Imaging Healthcare

AI Verdict

Tool A, Rapid RV/LV, is a specialized AI tool for rapid assessment of pulmonary embolism severity by measuring right and left ventricle ratios from CTPA scans. In contrast, Tool B, uOmnispace.MR, is a broader AI-powered software for comprehensive magnetic resonance (MR) image analysis across diverse clinical applications, including cardiac imaging. While both offer AI-driven cardiac analysis and are FDA-cleared, their differing imaging modalities (CTPA vs. MR) and specific clinical focuses make them adjacent rather than direct competitors.

Choose Rapid RV/LV if…

Choose Rapid RV/LV if your primary need is a rapid, AI-powered assessment of pulmonary embolism severity from CTPA scans. This tool is ideal for emergency departments or critical care settings where quick, objective measurement of RV/LV ratios is crucial for patient triage and management, reducing inter-rater variability in a time-sensitive environment.

View Rapid RV/LV →

Choose uOmnispace.MR if…

Choose uOmnispace.MR if you require a comprehensive, AI-powered platform for advanced magnetic resonance image analysis across multiple clinical applications. This tool is best suited for radiology departments needing detailed post-processing, AI-driven segmentation for various MR studies (e.g., cardiac function, brain perfusion, spectroscopy), and multi-user access for complex case review and research.

View uOmnispace.MR →

Reviewed by Pouyan Golshani, MD — Interventional Radiologist

Quick Comparison

Feature Rapid RV/LV uOmnispace.MR
Pricing Contact vendor for pricing information. Contact for pricing
Deployment Unknown Software-only medical device; can run standalone or integrated with other cleared applications on standard off-the-shelf PCs; supports remote multi-user access on a network. The broader uOmnispace platform is available as SaaS, on-premise, or hybrid.
BAA Available Yes AI-estimated Yes AI-estimated
FDA Status Cleared AI-estimated Cleared AI-estimated
HIPAA Yes AI-estimated Yes AI-estimated

Head-to-Head

AI-generated assessment across six dimensions based on each tool's documented features and compliance posture. Grounded in public data — not a substitute for hands-on evaluation.

Usability

Rapid RV/LV

Rapid RV/LV emphasizes rapid results, annotated images, and reduced inter-rater variability, suggesting a streamlined user experience. RapidAI's broader platform focuses on reducing cognitive burden for radiologists and seamless integration with existing PACS and EHR systems, which directly enhances usability in critical workflows.

Clinical Value

Rapid RV/LV

Both tools are FDA-cleared and offer significant clinical value. However, Rapid RV/LV, as part of the RapidAI platform, explicitly highlights its role in reducing mortality and improving outcomes in acute conditions like PE and stroke, backed by over 700 clinical studies and influencing treatment guidelines. While uOmnispace.MR offers broad applications, its specific, high-impact clinical outcomes are less detailed in the provided information.

Pricing & Value

Rapid RV/LV

Rapid RV/LV provides some transparency regarding its pricing model, stating an annual subscription and a starting price for a single module in the US. It also explicitly aims to deliver cost and time savings through increased efficiency. uOmnispace.MR's pricing remains opaque, making a direct comparison of value difficult, despite its broader platform offering 'Software Upgrades for Life'.

Enterprise Readiness

Rapid RV/LV

Both tools demonstrate strong enterprise readiness with FDA clearance, HIPAA compliance, BAA availability, and flexible deployment options. RapidAI's 'Rapid Edge Cloud' offers a robust, secure, and integrated hybrid infrastructure specifically designed for healthcare, with a proven track record across over 2,500 hospitals in more than 100 countries. This extensive global deployment and emphasis on a purpose-built platform give it a slight edge.

Innovation

uOmnispace.MR

While RapidAI is a pioneer in 'deep clinical AI' with extensive validation in acute care, uOmnispace.MR, as part of United Imaging Intelligence, demonstrates a broader and more diverse innovative approach. This includes advancements like dynamic MRI imaging, multimodal foundation models for report generation, and even robotic-arm-powered autonomous ultrasound, indicating a wider and potentially more futuristic scope across multiple modalities.

Support & Docs

Rapid RV/LV

RapidAI explicitly offers 24/7/365 customer support via email and phone with multiple international contact numbers, alongside comprehensive resources like guides and a help center. United Imaging Healthcare also provides dedicated customer service with local engineers and comprehensive service agreements, but RapidAI's stated round-the-clock global availability gives it an advantage in accessibility.

Feature-by-Feature

Detail beyond the Quick Comparison summary. For pricing, deployment, BAA, FDA, and HIPAA see the Overview tab.

Feature Rapid RV/LV uOmnispace.MR
Tool Name Rapid RV/LV uOmnispace.MR
Company RapidAI (formerly iSchemaView) Shanghai United Imaging Healthcare Co., Ltd.
Primary Function/Focus Rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios from CTPA scans. Comprehensive magnetic resonance (MR) image analysis, supporting diverse clinical applications including brain, breast, and cardiac imaging with advanced post-processing tools and AI-driven segmentation.
Imaging Modality CTPA scans MR images
Key Specialties Cardiology, Pulmonology, Radiology Cardiology, Neurology, Radiology
Specific AI Capabilities AI-powered analysis of CTPA images, Automated measurement of right and left ventricle diameters, Calculation of RV/LV ratio, Annotated images showing ventricular measurements. AI-driven cardiac ventricular segmentation, MR Spectroscopy (SVS and CSI), Perfusion analysis (e.g., Brain Perfusion), Vessel analysis for MR vascular images, Cardiac function analysis.

Videos

Demos, reviews, and walkthroughs featuring Rapid RV/LV and uOmnispace.MR.

Loading videos…
Videos need JavaScript to load. Search YouTube directly →

View all on YouTube

Frequently Asked Questions

Rapid RV/LV by RapidAI analyzes CTPA scans specifically for the rapid assessment of pulmonary embolism severity by automatically measuring right and left ventricle ratios. uOmnispace.MR by Shanghai United Imaging Healthcare Co., Ltd. is designed for comprehensive magnetic resonance (MR) image analysis, supporting diverse clinical applications including brain, breast, and cardiac imaging with advanced post-processing tools and AI-driven segmentation.
Rapid RV/LV provides AI-powered analysis of CTPA images for automated measurement of right and left ventricle diameters and calculates the RV/LV ratio, which is a key indicator of pulmonary embolism severity. uOmnispace.MR offers AI-driven cardiac ventricular segmentation and general cardiac function analysis as part of its broader MR image analysis capabilities.
Rapid RV/LV integrates with the Rapid PE solution and offers triage and notification capabilities as part of the broader Rapid platform. uOmnispace.MR can run standalone or be integrated with other cleared applications, and its broader uOmnispace platform supports various imaging modalities and communicates via the DICOM3.0 standard.
Rapid RV/LV delivers rapid results within minutes of a CTPA scan, providing AI-powered analysis and automated ventricular measurements to help physicians quickly assess pulmonary embolism severity.
uOmnispace.MR provides advanced features such as stitching for full-format MR images, dynamic studies analysis, MR Spectroscopy (SVS and CSI), perfusion analysis (e.g., Brain Perfusion), and vessel analysis for MR vascular images.
AI Tool Finder
AI-powered search. Results may not be comprehensive.